CTRI/2023/09/057216
Not yet recruiting
未知
A Pilot clinical trial to explore the effectiveness of selected Siddha treatment instituted for Pakka vatham (Subacute and Chronic Ischemic Hemiplegic Stroke) at Ayothidoss Pandithar Hospital, NIS. - NI
il0 sites0 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- il
- Status
- Not yet recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Age between 18 – 70 years.
- •Ischemic stroke confirmed by brain magnetic resonance imaging or computed tomography.
- •Patients who have had a stroke for 3 months and above.
- •Those who have Hemiplegia after a stroke.
- •If the walking pattern is abnormal and the walking speed is less than 0\.8m / sec.
- •Modified Ranking scale (mRS) scores 3\-5 at the time of enrolment.
- •Pre\-stroke modified Rankin scale (mRS) less than or equal to 2\.
- •The patients who understand the research and have voluntary participation.
Exclusion Criteria
- •Neurological conditions other than stroke like Guillian\-barre syndrome, Chronic Inflammatory demyelinating polyradiculopathy, Parkinson’s disease, Transverse myelitis.
- •Patient who had stroke incidence before 1 year.
- •Patient without intact higher mental function and cognition assessed by MOCA scale .
- •Patients with grade 3 arthritis and traumatic injuries and Traumatic Brain Injuries.
- •Other chronic disabling pathologies orthopedic injuries that could impair locomotion.
- •Participating in other clinical trial within 30 days prior screening.
- •History of major depressive or other severe psychiatric disorders.
- •Current concomitant institution of traditional and/or complementary treatments for other or same condition.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Phase 2
A Study to find the Effectiveness of Siddha treatment for Vathakarsanam (Diabetic Peripheral Neuropathy)Health Condition 1: E114- Type 2 diabetes mellitus with neurological complicationsCTRI/2024/06/069492I
Not yet recruiting
Phase 2
Clinical Study to evaluate the effectiveness of Linga chendooram in the management of Uthiravatha suronitham (Rheumatoid arthritis)Health Condition 1: M059- Rheumatoid arthritis with rheumatoid factor, unspecifiedCTRI/2023/09/057492I
Not yet recruiting
Not Applicable
Clinical trial to evaluate efficacy of chitramutti madakku thailam peechu therapy in the management of thandagavathsmHealth Condition 1: M959- Acquired deformity of musculoskeletal system, unspecifiedCTRI/2023/10/058490nil
Completed
Not Applicable
A pilot clinical trial to evaluate the efficacy and safety of R:GEN(Selective retina therapy) which induce to reduce drusen in patients with intermediate dry Age-related Macular DegeneratioDiseases of the eye and adnexaKCT0003227The Catholic University of Korea, Yeouido St. Mary's Hospital20
Recruiting
Phase 2
Evaluation of the effectiveness of Cyclotide complex herbal syrup in preventing COVID-19 virus in exposed individualsIRCT20160131026298N4Bagheiat-allah University of Medical Sciences60